Jim Hoffman: Affinity-Based Blood Purification as a Potential Alternative to Plasma Exchange
Jim Hoffman, Former Technical Advisor at Cygnus Technologies, LLC, posted on LinkedIn:
“A business model for improved therapeutic extracorporeal blood purification methods to follow that are capable of depleting toxic levels of extracellular chromatin from the blood.
These newer affinity-based methods , which effectively deplete extracellular chromatin and allow patients to keep their own blood with greatly reduced toxic levels of extracellular chromatin, should be evaluated as a replacement for more expensive and likely less effective Therapeutic Plasma Exchange (TPE).
This could greatly increase badly needed affordable access to treatment and potentially prevent and treat chronic illness disease progression more efficaciously than TPE.
A small sampling of the research implicating elevated extracellular chromatin contributing to multi-organ injury and disease progression:”
Find more posts featuring Jim Hoffman on Hemostasis Today.
-
Jul 13, 2026, 18:54Alfonso J. Tafur: New Evidence on Perioperative Anticoagulation in Cancer at ISTH 2026
-
Jul 13, 2026, 18:42Jessica Garcia: Thrombin Generation in Type 3 VWD With an Inhibitor on Emicizumab
-
Jul 13, 2026, 18:19Fionnuala Ní Áinle: High-Quality Evidence for DVT Diagnosis in Pregnancy at ISTH 2026
-
Jul 13, 2026, 17:39Pascal Boulanger: Send a Postcard to Your Lab Staff From ISTH 2026
-
Jul 13, 2026, 17:21Stefano Navarro: Presenting Our Recently Published Article at ISTH 2026
-
Jul 13, 2026, 17:12Santagata Davide: A Great Session and an Incredible Opportunity to Present Our Research at ISTH 2026
-
Jul 13, 2026, 16:26Real-World Data Across Time Reveal Important Advances in Hemophilia Treatment – ATHN
-
Jul 13, 2026, 16:19Mary Cushman: Celebrating Our Incredible ISTH Council Members in Paris
-
Jul 13, 2026, 16:17Wolfgang Miesbach: Gene Therapy Shows Promising Early Results in Adolescents With Hemophilia B at ISTH 2026